We’ve decided to exit our position in OrthoLogic Corporation (NASDAQ:CAPS) at its $0.90 close yesterday. We opened the position at $0.60, so we’re up 50% on an absolute basis. The S&P500 Index closed at 752.83 on February 27, the day we opened the position, and closed yesterday at 1,068.76, which means we’re up 8.0% on [...]
Posts Tagged ‘OrthoLogic Corporation (NASDAQ:CAPS)’
Capstone Therapeutics (NASDAQ:CAPS) position exited
Posted in Stocks, Biotechnology Value Fund, Net Cash Stocks, OrthoLogic Corporation (NASDAQ:CAPS), tagged Net Cash Stock, OrthoLogic Corporation (NASDAQ:CAPS) on September 17, 2009 | Leave a Comment »
Capstone Therapeutics (NASDAQ:CAPS) Q2 update
Posted in Stocks, Biotechnology Value Fund, Net Cash Stocks, OrthoLogic Corporation (NASDAQ:CAPS), tagged Biotechnology Value Fund, Net Cash Stock, OrthoLogic Corporation (NASDAQ:CAPS) on August 13, 2009 | Leave a Comment »
OrthoLogic Corporation (NASDAQ:CAPS) has filed its 10Q for the quarter ended June 30, 2008. We’ve been following CAPS (see our post archive here) because it trades below its net cash value and Biotechnology Value Fund (BVF) has a 13.42% holding. It’s an unusual holding for us because BVF’s holding is passive. CAPS is a development [...]
OrthoLogic Corporation (NASDAQ:CAPS) 10K update
Posted in Activist Investors, Biotechnology Value Fund, Net Cash Stocks, OrthoLogic Corporation (NASDAQ:CAPS), tagged Biotechnology Value Fund, Net Cash Stock, OrthoLogic Corporation (NASDAQ:CAPS) on March 16, 2009 | Leave a Comment »
OrthoLogic Corporation (NASDAQ:CAPS) has filed its 10K for the year ended December 31, 2008. We’ve been following CAPS (see our post archive here) because it trades below its net cash value and Biotechnology Value Fund (BVF) has disclosed a 13.42% holding. It’s an unusual holding for us because BVF’s holding is passive. At CAPS’s $0.51 [...]
OrthoLogic Corporation (NASDAQ:CAPS)
Posted in Activist Investors, Biotechnology Value Fund, Net Cash Stocks, Greenbackd Portfolio, OrthoLogic Corporation (NASDAQ:CAPS), tagged Biotechnology Value Fund, Net Cash Stock, OrthoLogic Corporation (NASDAQ:CAPS) on February 27, 2009 | 2 Comments »
OrthoLogic Corporation (NASDAQ:CAPS) is a little unusual for us. While it trades below its net cash value and Biotechnology Value Fund (BVF) has disclosed a 13.42% holding, BVF’s holding is passive. At CAPS’s $0.60 close yesterday it has a market capitalization of $24.4M. We estimate the net cash value to be 80% higher at $1.08 [...]

